1 completed. 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 1 | Completed 1 |
Follow Paraproteinemia: new trials by email Literature Review of Paraproteinemia trials Research Report on Paraproteinemia
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Lenalidomide and Ofatumumab in Treating Participants With Previously Treated Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma Lenalidomide, Ofatumumab - Chronic Lymphocytic Leukemia, Fatigue | Phase 2 | Completed | M.D. Anderson Cancer Center | 36 | 2010-01-19 | 2019-05-07 |
Agammaglobulinemia (1) · Fatigue (1) · Fever (1) · Leukemia, Lymphocytic, Chronic, B-Cell (1) · Lymphadenopathy (1) · Lymphocytosis (1) · Paraproteinemias (1) · Thrombocytopenia (1)
Blood Platelet Disorders (1) · Blood Protein Disorders (1) · Body Temperature Changes (1) · Chronic Disease (1) · Cytopenia (1) · Disease Attributes (1) · Hematologic Diseases (1) · Hemic and Lymphatic Diseases (1) · Immune System Diseases (1) · Immunologic Deficiency Syndromes (1) · Immunoproliferative Disorders (1) · Leukemia (1) · Leukemia, B-Cell (1) · Leukemia, Lymphoid (1) · Leukocyte Disorders (1)
Lenalidomide (1) · ofatumumab (1)
M.D. Anderson Cancer Center (1)
United States (1)
P30CA016672 (1)